Tokai Pharmaceuticals CEO Gregory Flesher's 2018 pay slips 2% to $943K
Tokai Pharmaceuticals reports 2018 executive compensation
By ExecPay News
Published: May 15, 2019
Tokai Pharmaceuticals reported fiscal year 2018 executive compensation information on May 15, 2019.
In 2018, three executives at Tokai Pharmaceuticals received on average a compensation package of $666K, a 9% increase compared to previous year.
Average pay of disclosed executives at Tokai Pharmaceuticals
Gregory J. Flesher, Chief Executive Officer, received $943K in total, which decreased by 2% compared to 2017. 49% of Flesher's compensation, or $460K, was in salary. Flesher also received $191K in non-equity incentive plan, $191K in option awards, $99K in stock awards, as well as $1.4K in other compensation.
Catherine C. Turkel, President, received a compensation package of $626K, which increased by 9% compared to previous year. 57% of the compensation package, or $358K, was in salary.
Jon S. Kuwahara, Senior Vice President of Finance and Administration, earned $430K in 2018, a 66% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on May 15, 2019.